Press release
Head and Neck Cancer Therapeutics Market Progresses for Huge Profits During 2016-2024
Get access to full summary @: http://www.persistencemarketresearch.com/market-research/head-and-neck-cancer-therapeutics-market.asp
Cancers of squamous cells present in the linings of larynx, throat, nose, salivary glands, lips, mouth are collectively called as head and neck cancers. According to World Health Organization (WHO), globally more than 550,000 new cases of head and neck cancer are diagnosed per year with around 300,000 deaths annually. Head and neck cancer is the sixth most common type of cancer and accounts for 56% of all cancers. Treatment of head and neck cancer presents a significant challenge to physicians as the choice of treatment varies from patient to patient and location of the tumor. Head and neck cancers ate often treated with surgery, but the complexity of facial structures and functions limits the surgical treatments. Surgery for head and neck cancer changes some of the functions such as chewing, swallowing, talking, etc.
Surgical therapy in combination with radiation therapy is the most preferred treatment regime by physicians. However, currently available treatment options for head and neck cancer do not result in improvement in survival rate, and head and neck cancer survival rate has decreased from 80% to 50%in last ten years. Recent developments in advanced chemotherapy and radiotherapy allow preserving some of the functions of the face. The introduction of targeted molecular therapy such as gene therapy, monoclonal antibodies, antibody drug conjugates, etc. has opened up huge potential for the growth of head and neck cancer therapeutics market.
The global market for anti-neoplastic agents is segmented on basis of treatment type, disease indication, end user and geography. Based on treatment type, global head and neck cancer therapeutics market has been segmented as follow: Chemotherapy, Radiation Therapy, External Radiation Therapy, Internal Radiation Therapy, Surgery, Targeted Therapy. Based on disease indication, global head and neck cancer therapeutics market has been segmented as follow: Laryngeal Cancer, Lip and Oral Cavity Cancer, Nasopharyngeal Cancer, Oropharyngeal Cancer, Salivary Gland Cancer, Others. Based on end user, global head and neck cancer therapeutics market has been segmented as follow: Hospitals, Specialty Clinics, Ambulatory Surgical Centers.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/11734
Increasing smoking rate, tobacco consumption and incidence of HPV-caused cancers are the factors primarily responsible for growing prevalence of head and neck cancers such as oral cavity cancer, nasopharyngeal cancer, etc. Based on treatment type, global head and neck cancer therapeutics market is classified as chemotherapy, radiation therapy, and surgery. Surgery is expected to lead the global market for head and neck cancer therapeutics over the forecast period as it is the choice of therapy by physicians.
Radiation therapy is used to prevent the recurrence of cancer and is expected to contribute second largest share in the global head and neck cancer therapeutics market. Chemotherapy is used as an adjunct to other therapies and thus hold little share in global head and neck cancer therapeutics market.
Based on disease indication, global head and neck cancer therapeutics market has been segmented into laryngeal cancer, lip and oral cavity cancer, nasopharyngeal cancer, oropharyngeal cancer, salivary gland cancer and others. Lip and oral cavity cancer indication type segment is expected to contribute the highest share in the global market for head and neck cancer therapeutics market owing to the high global prevalence of cancer. GLOBOCAN 2012 reports the highest prevalence of 3.1% in 2012 affecting 467,157 people affected by lip and oral cancer globally.
Based on the end user, the global head and neck cancer therapeutics market has been segmented into hospitals, specialty clinics, and ambulatory surgical centers. Hospital end user segment is anticipated to contribute the maximum share among end users.
Based on the regional presence, global head and neck cancer therapeutics market is segmented into five key regions viz. North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. North America will continue to dominate the global head and neck cancer therapeutics market for due to high prevalence HPV-induced cancers and high smoking rate. Europe is expected to hold second largest market share in global head and neck cancer therapeutics market.
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/11734
Some of the major players operating in the global head and neck cancer therapeutics market are AbbVie Inc., Acceleron Pharma, Inc., AB Science SA, AstraZeneca Plc., Astellas Pharma Inc., Bayer AG, Boston Biomedical, Inc., Bristol-Myers Squibb Company and others.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Head and Neck Cancer Therapeutics Market Progresses for Huge Profits During 2016-2024 here
News-ID: 621588 • Views: …
More Releases from Persistence Market Research
Hypercalcemia Treatment Market Trends Indicate Strong Growth in Advanced Therape …
The global hypercalcemia treatment market is experiencing a significant surge, driven by rising incidences of hypercalcemia, increasing cancer prevalence, and an expanding geriatric population. Hypercalcemia is defined as a condition where serum calcium levels exceed 2.6 mmol/L, leading to complications such as weakened bones, kidney stones, cardiovascular issues, and neurological disorders. Treatment strategies range from pharmacological interventions like bisphosphonates, calcimimetics, and denosumab to surgical approaches targeting overactive parathyroid glands. The…
Surface Roughness Measurement Market, Precision Technologies Driving Quality Con …
The global surface roughness measurement market is witnessing robust growth as industries prioritize high-precision manufacturing, stringent quality standards, and the integration of advanced metrology technologies. Surface roughness measurement systems are essential tools for evaluating the texture and finish of machined components, ensuring compliance with design specifications and enhancing product performance. According to Persistence Market Research (PMR), global surface roughness measurement sales revenue reached US$ 834.0 million in 2022. Over the…
Onychomycosis Treatment Market Driven by Rising Fungal Infection Cases | Persist …
The global onychomycosis treatment market is witnessing robust growth, driven by an increasing prevalence of fungal nail infections and advancements in medical technology. Onychomycosis, a common nail disorder caused primarily by dermatophytes, yeasts, and non-dermatophyte molds, affects millions globally and presents both cosmetic and medical challenges. Diagnostic techniques have evolved significantly, with tools such as optical coherence tomography and confocal microscopy allowing for precise visualization of fungal infections at the…
Smart Pneumatics Market, Powering Predictive Maintenance and Operational Intelli …
The global smart pneumatics market is rapidly evolving, driven by the convergence of pneumatic technology with intelligent sensors, data analytics, and the Industrial Internet of Things (IIoT). Smart pneumatics systems are transforming conventional manufacturing and automation processes by enabling real-time monitoring, predictive maintenance, and energy optimization. Persistence Market Research (PMR) reports that global smart pneumatics sales stood at US$ 3.4 billion in 2022 and are projected to reach US$ 6.3…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
